Clinical Trial Update: A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating cinacalcet's ability to help end-stage renal disease patients meet K/DOQI targets for secondary hyperparathyroidism; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Amgen | Conditions: Anemia, Secondary Hyperparathyroidism | Phase 4 | Status: COMPLETED | Results posted: 2011-07-13